Brief: Concord Biotech Commences Production At New Valthera Facility
25/03/2025 08:02
March 25 (Reuters) - Concord Biotech Ltd CONB.NS: CONCORD BIOTECH LTD - COMMENCES PRODUCTION AT NEW VALTHERA FACILITY CONCORD BIOTECH - COMMENCED PRODUCTION OF INJECTABLE AT CO'S FACILITY SITUATED AT VALTHERA Further company coverage: CONB.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval